Chemoinformaics analysis of 1,6-Dioxaspiro[4,4]nona-2,8-diene, 7-(2,4)-hexadiynylidene
Molecular Weight | 202.253 | nRot | 2 |
Heavy Atom Molecular Weight | 188.141 | nRig | 13 |
Exact Molecular Weight | 202.099 | nRing | 2 |
Solubility: LogS | -2.632 | nHRing | 2 |
Solubility: LogP | 1.828 | No. of Aliphatic Rings | 2 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 29 | No. of Aliphatic Hetero Cycles | 2 |
No. of Heavy Atom | 15 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 13 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 2 | No. of Arom Bond | 0 |
nHA | 2 | APOL | 32.6491 |
nHD | 0 | BPOL | 17.5169 |
QED | 0.64 |
Synth | 5.147 |
Natural Product Likeliness | 2.776 |
NR-PPAR-gamma | 0.045 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.001 |
Pgp-sub | 0.006 |
HIA | 0.006 |
CACO-2 | -4.525 |
MDCK | 0.0000142 |
BBB | 0.885 |
PPB | 0.904286 |
VDSS | 0.817 |
FU | 0.0879073 |
CYP1A2-inh | 0.368 |
CYP1A2-sub | 0.425 |
CYP2c19-inh | 0.462 |
CYP2c19-sub | 0.819 |
CYP2c9-inh | 0.083 |
CYP2c9-sub | 0.628 |
CYP2d6-inh | 0.935 |
CYP2d6-sub | 0.88 |
CYP3a4-inh | 0.626 |
CYP3a4-sub | 0.32 |
CL | 7.306 |
T12 | 0.572 |
hERG | 0.004 |
Ames | 0.986 |
ROA | 0.676 |
SkinSen | 0.94 |
Carcinogencity | 0.974 |
EI | 0.108 |
Respiratory | 0.966 |
NR-Aromatase | 0.304 |
Antiviral | Yes |
Prediction | 0.587475 |